CTNM
Contineum TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CTNM vs peer average
51/100
CTNM vs. peer average (D vs. D)
Grade spread
B 1 · C 2 · D 3 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ACIU is the first available peer comparator.
AC Immune is another small-cap clinical-stage CNS biotech; useful as a binary-development comparator, though its indication set is not a close match to CTNM’s IPF/chronic-pain focus.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CTNM
Contineum Therapeutics
ACIU
AC Immune
Grade
D
D
Momentum
64
46
Value
41
41
Sentiment
45
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ACIU
CTNM / ACIU
Grade Position
In line
CTNM vs. peer average (D vs. D)
51/100
Momentum
64
CTNMValue
41
CTNMSentiment
45
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CTNM
ACIU is the first peer returned for this comparison set.